HealthEquity, Inc.: stock overview

HQYNASDAQTechnology · Services-Business Services, NEC

Price

$103.46

November 13, 2026Market cap $8.7B

What Ploutos Investor adds for HealthEquity

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 14 fiscal years, from FY2013
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

HealthEquity had revenue of $1.4B over the last 12 months and net income of $236M, a net margin of 17.4%. Revenue grew by 12.4% a year on average over the last 5 years. At $103.46 the shares trade at a P/E of 37.0. It has net debt of $675M. It pays no dividend.

From its SEC filings (latest fiscal year to January 31, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$8.7B
84.48M shares
P/E
37.0
Revenue, 12 months
$1.4B
+12.4% a year over 5 years
Net margin
17.4%
FY2025: 16.4%, above 81% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+14.6% a year over 2 years

  • FY2026Jan 31, 202610-K
    Revenue$1.3B
  • FY2025Jan 31, 202510-K
    Revenue$1.2B
  • FY2024Jan 31, 202410-K
    Revenue$1,000M

Fiscal years in figures

HQY's revenue, profit, cash flow and dividend with each year-end price, from FY2013 to FY2023, 11 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $7.2B
$8.7B
Enterprise value 
$9.4B
P/E 
37.0
EV / EBIT 
26.8
EV / Revenue 
6.9
P/B 3-year median: 3.4
4.4
FCF yield 3-year median: 3.7%
5.6%
Earnings yield 3-year median: 1.0%
2.7%

Profitability

Gross margin 
71.3%
Operating margin 
25.8%
Net margin 3-year median: 8.1%
17.4%
ROIC 
8.8%
ROIC, 5-year average 
3.0%
ROE 
11.3%

Growth

Revenue, yearly change 
+9.5%
EPS, yearly change 
+125.7%
FCF, yearly change 
+34.7%
Revenue, average a year 
+12.4%
EPS, average a year 
+83.0%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$256M
Total debt 
$971M
Of which operating leases 
$40M
Net debt 
$675M
Net debt / EBITDA 
1.3x
Interest cover 
6.7x
Current ratio 
2.99

Balance sheet of July 31, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
3.42%
Total returned 
3.42%
Shares, yearly change 
-2.3%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 73).

Gross margin

69.5%

Above 59% of the 293 companies in its industry, and 86% of all.

Operating margin

24.6%

Above 90% of the 462 companies in its industry, and 88% of all.

Net margin

16.4%

Above 81% of the 473 companies in its industry, and 77% of all.

ROE

10.2%

Above 63% of the 398 companies in its industry, and 61% of all.

ROA

6.4%

Above 73% of the 462 companies in its industry, and 78% of all.

Revenue growth

9.5%

Above 52% of the 461 companies in its industry, and 60% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
HEALTHEQUITY, INC.
Exchange
NASDAQ
Industry (SIC)
7389 · Services-Business Services, NEC
Fiscal year ends
January 31
Latest annual report
January 31, 2026
Reporting currency
USD
Shares
84.48M

Other companies: Technology

The largest companies of the same sector, each with its own page.

The Technology sectorAll companies

The full analysis

What do HealthEquity's filings show?

These are HealthEquity's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about HQY

Didn't find what you were looking for?

Ask us
What is HQY's market cap?

HealthEquity, Inc.'s market cap is $8.7B, at a price of $103.46 on November 13, 2026 and 84.48M shares.

What is HQY's P/E?

HQY's P/E is 37.0, on earnings per share of $2.77 over the last 12 months.

How much revenue does HQY have?

HealthEquity had revenue of $1.4B over the last 12 months. Over the last 5 years it changed by +12.4% a year on average.

Does HQY pay a dividend?

No. HealthEquity paid no regular dividend over the last 12 months.

Where do the figures come from?

From HealthEquity, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.